hiTDExs PKM2 were reported to exhibit PKM2-BCL2 mediated anti-apoptotic activity and inhibit cisplatin-mediated apoptosis in non-small cell lung cancer (NSCLC) cells [79]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.